Monoclonal Antibodies Against Zika Show Promise in Monkey Study
Using blood samples from an individual previously infected with Zika virus, scientists funded by the National Institute of Allergy and infectious diseases (NIAID), part of the National Institutes of Health, have developed an antibody-based zika virus therapeutic that protected monkeys from infection. Because monoclonal antibodies are generally safe, they believe that this antibody cocktail might be appropriate for uninfected pregnant women; because the antibodies will likely cross the placenta, the researchers hope that administration during pregnancy may protect both the pregnant woman and the fetus from Zika virus. The investigators are hoping to test this concept by pursuing studies in people.
Zika virus particles (red) shown in African green monkey kidney cells.
NIAID
The scientists isolated immune cells from the patient's blood and used them to make 91 monoclonal antibodies -- immune system fighters designed to bind to a specific part of an invading virus or bacterium to stop the infection. They identified three antibodies that bound to Zika virus surface proteins, and each neutralized the virus. The researchers then administered a combination of these antibodies to rhesus macaques and exposed the animals to Zika virus one day later. During the 21-day study, all four monkeys who received the antibody cocktail showed no virus replication.
Researchers at the University of Miami and The Scripps Research Institute led the project with collaborators in Brazil and the U.S.
Original publication
Other news from the department science
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Last viewed contents
Scientists find brown fat master switch - Mouse study could lead to novel treatment for obesity in humans
Max-Planck-Institut für Dynamik und Selbstorganisation - Göttingen, Germany
CureVac Receives Regulatory Approval to Initiate Phase 1 Clinical Trial of its SARS-CoV-2 Vaccine Candidate - Trial will start promptly and will be conducted in Germany and Belgium
Increased deep sleep benefits your heart - Setting up a start-up to further develop the findings and transfer them into practice
List_of_Nepenthes_species
By decoding how HPV causes cancer, researchers find a new potential treatment strategy
Category:Intensive_care_medicine
Vedolizumab is an effective treatment for Crohn's disease and ulcerative colitis
